Eric E. Poma - 27 Apr 2022 Form 4 Insider Report for Molecular Templates, Inc.

Transaction date: 27 Apr 2022
Net transaction value: +$24,251
Issuer symbol: N/A
Form type: 4
Filing time: 29 Apr 2022, 08:00:31 UTC
Previous filing: 17 Feb 2022
Next filing: 17 Feb 2023
SEC filing: View on sec.gov
Role: Chief Executive Officer and Chief Scientific Officer, Director
Signature: /s/ Eric E. Poma

Key filing fact

Eric E. Poma filed Form 4 for Molecular Templates, Inc. on 29 Apr 2022.

Key facts

This page summarizes Eric E. Poma's Form 4 filing for Molecular Templates, Inc..
4 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 29 Apr 2022, 08:00.

Change

Previous filing in this sequence was filed on 17 Feb 2022.
Current net transaction value: +$24,251.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

MTEM transaction

Common Stock

Options Exercise

Transaction value: $4,850
Shares: +6,831
Change %: +2.8%
Price: $0.7100
Shares after: 250,290
Date: 27 Apr 2022
Ownership: Direct

MTEM transaction

Common Stock

Options Exercise

Transaction value: $19,401
Shares: +27,325
Change %: +11%
Price: $0.7100
Shares after: 277,615
Date: 27 Apr 2022
Ownership: Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

MTEM transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -6,831
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,831
Exercise price: $0.7100
Footnotes: F1

MTEM transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -27,325
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,325
Exercise price: $0.7100
Footnotes: F2

^* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id	Content
F1	This option, representing a right to purchase a total of 6,831 shares, became exercisable in equal monthly installments over a five-year period beginning on July 10, 2012.
F2	This option, representing a right to purchase a total of 27,325 shares, became exercisable in equal monthly installments over a five-year period beginning on July 10, 2012.

Remarks:

Chief Executive Officer and Chief Scientific Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .